Xcel Array™ and Cancer DSA®
At Almac we have developed a range of microarrays to provide the optimal platform for biomarker discovery and development across multiple disease areas as well as within specific disease areas. These arrays are high density transcriptome based microarrays based on the gold standard Affymetrix GeneChip® platform.
The two main product lines are Xcel™ array discovery platform for studies in multiple disease areas and Cancer DSA® arrays, for studies within specific disease areas.
All the arrays have been designed using a combination of large-scale in-house sequencing projects, gene expression studies and carefully curated public databases. The arrays are optimised for use with both fresh frozen and formalin fixed paraffin embedded (FFPE) samples which aids in the discovery of clinically relevant biomarkers
The Xcel™ array is the optimal platform for biomarker discovery that enables the identification of biomarkers within multiple disease areas.
Xcel™ is a high density transcriptome based microarray built on the industry standard Affymetrix GeneChip® platform. The content of Xcel™ has been derived from high quality proprietary sequence data, as well as mining public gene expression and sequence databases
The Xcel™ array contains 97,000 transcripts; significantly more than is available on any other platform and the technology is optimised for use with Formalin Fixed Paraffin Embedded (FFPE) tissue.
Our Cancer DSA® research tools are the first high-density microarrays which focus on the transcriptome of an individual disease. They contain the most comprehensive information available for the disease under investigation on a single array and enable you to obtain robust data from FFPE and frozen samples, while delivering additional information on the disease setting.
Each Cancer DSA® research tool is designed around an individual disease and tissue specific transcriptome; and as a result contains significant, additional and relevant information.
The portfolio of Cancer DSA® arrays:
- Breast Cancer DSA®
- Colorectal Cancer DSA®
- Ovarian Cancer DSA®
- Lung Cancer DSA®
- Prostate Cancer DSA®